<DOC>
	<DOCNO>NCT01393925</DOCNO>
	<brief_summary>This prospective , double blind , placebo-controlled , parallel group study conduct first affiliated hospital Sun yat-sen university Guangzhou , China . Patients age 18-65 ( ASA I-II ) undergo elective gynecologic laparoscopic surgery general anesthesia involve study . According previous study pilot trial , sample size estimate 120 subject . All eligible patient randomly assign one three group : Group A ( single parecoxib ) receive parecoxib 40mg 30min end surgery ; Group B ( multiple parecoxib ) receive parecoxib 40mg 30min end surgery , 8h 20h surgery , respectively , Group C ( Control group ) receive normal saline . All patient manage standard propofol-remifentanil base total intravenous anesthesia protocol . The incidence intensity shoulder pain rest motion evaluate independent doctor blind medication group use visual analog scale ( VAS ) 6h , 24h 48h postoperatively . Other type pain ( e.g . trocar wound visceral pain ) , side effect ( postoperative nausea vomiting , itching , dizziness , oversedation ) assess well . At end observation , intensity maximum pain record , effect shoulder pain four variable regard quality life ( activity , mood , walk sleep ) assess use modify Brief Pain Inventory ( BPI ) questionnaire .</brief_summary>
	<brief_title>Effect Parecoxib Postoperative Shoulder Pain After Gynecological Laparoscopy .</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>female age 1865yr American Society Anesthesiologists ( ASA ) physical status classification III Body Mass Index ( BMI ) 1825kg/m2 schedule elective gynecologic laparoscopic surgery patient history severe cardiac , pulmonary , hepatic , renal disease , chronic drug alcohol abuse ; presence preoperative shoulder pain chronic pain syndrome , longterm use analgesic ; allergy contraindication nonsteroidal antiinflammatory drug ( allergy , peptic ulcer disease , gastroesophageal reflux disease , renal insufficiency , coagulopathy ) drug use study ; whose pain evaluation judge unreliable</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>